Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
See following websites on indications and recommendations for testing:
www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html
This test provides simultaneous, qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA, influenza A RNA, and influenza B RNA in upper respiratory tract specimens from patients with flu-like illness that may be due to coronavirus disease 2019 (COVID-19) and/or influenza.
Fact sheets for this FDA emergency use authorized assay can be found at the following URL:
For healthcare providers: https://www.fda.gov/media/141885/download
For patients: https://www.fda.gov/media/141886/download
See Coronavirus Disease 2019 (COVID-19), Influenza, and Respiratory Syncytial Virus Testing Algorithm in Special Instructions.
Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)